First Ascent Biomedical raised $6M in an angel investment led by Vidal Duart Enterprises, Inc. to revolutionize cancer treatment with personalized technology.
First Ascent Biomedical has secured a $6 million investment from Vidal Duart Enterprises, Inc., along with co-investment from Techstars. The funding will be used to enhance operations and establish a state-of-the-art lab in Florida, focusing on personalized cancer treatment technologies.
Company Information
Company
First Ascent Biomedical
Location
Miami, Florida, United States
About
First Ascent Biomedical is a leader in Functional Precision Medicine, leveraging advanced technologies to personalize cancer treatment. The company focuses on personalized cancer care with their innovative platform that integrates drug testing, DNA/RNA sequencing, and AI-guided tumor weakness mapping. Their technology aims to improve patient survival by moving away from one-size-fits-all approaches and providing tailored treatment strategies. They are committed to making cancer care widely accessible, especially for underserved communities.
Fundz sees it the moment First Ascent Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.